Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

People with androgenetic alopecia may have a higher risk of severe COVID-19.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

No clear link between androgenetic alopecia and COVID-19 was found.

AGA might indicate higher risk for severe COVID-19.

Thuja orientalis and Thuja occidentalis essential oils have medicinal properties useful for developing treatments with antimicrobial and bioactive effects.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Long-COVID has diverse, long-term health impacts, especially in young people.

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

Skin symptoms linked to COVID-19 are hard to confirm, and more testing is needed to identify which are truly caused by the virus.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

COVID-19 reinfection may trigger alopecia areata.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Dogs with dermatomyositis, especially Collies and Shetland Sheepdogs, need better treatments for their skin and muscle inflammation.

COVID-19 patients in Thailand typically started losing hair about 30 days after infection, with women experiencing more severe hair loss.

Polycystic ovary syndrome, a disorder causing menstrual issues and infertility, can be treated with lifestyle changes, medication, herbal remedies, surgery, and assisted reproductive techniques like artificial insemination and IVF.

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

COVID-19 can cause hair loss and nail changes in some patients.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Low testosterone levels may lead to more severe COVID-19 outcomes.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Possible link between androgens and COVID-19 severity; more research needed.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.